Tag: Pentarins
Peptide-drug Conjugates: Potent and Selective Miniaturized Conjugates for the Treatment of...
Targeted therapeutics, including antibody-drug conjugates ADCs, designed to link targeted monoclonal antibodies, via a linker, to potent cell-killing payloads, have been a highly successful for creating...
Blend Therapeutics Appoints New Member to It’s Board of Directors and...
Earlier today, Blend Therapeutics, a biopharmaceutical company based in Watertown, MA involved in the discovery of new classes of medicines to treat cancer, announced...
